| Pharmaceutical active ingredients: |
| Lidocaine Hydrochloride |
| Available forms, composition and doses of Otoralgyl: |
| N / A |
| Otoralgyl medical category: |
| Human:Anaesthetics - local and generalAntipruritics and local anestheticsCardiac drugsClass IB antiarrythmicsTopical anesthetics used in the treatment of pruritus |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01BB01 - Lidocaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisF. Uhlmann-EyraudJohnson & Johnson |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Otophen | Chloramphenicol | Unidentified Pharmaceutical Company |
| Oto-Phen | Phenazone | Adcock Ingram |
| Oto-Phen Forte | Benzocaine; Ephedrine Hydrochloride; Phenazone; Potassium Hydroxyquinoline Sulfate | Adcock Ingram |
| Otopraf | Fludrocortisone Acetate; Lidocaine Hydrochloride; Neomycin Sulfate; Polymyxin B Sulfate | Prafa |
| Otopreven | Acetic Acid | Fortbenton Laboratorio Farmaceutico |
| Otoralgyl a la Phenylephrine | Lidocaine Hydrochloride; Phenylephrine Hydrochloride; Sodium Propionate | Johnson & Johnson |
| Otoralgyl Sulfamide | Lidocaine Hydrochloride; Sulfasuccinamide Sodium | Johnson & Johnson |
| Otorex | Benzocaine; Chlorobutanol; P-Dichlorobenzene; Turpentine Oil | Indoco Remedies |
| Otorinazol | Atropine Sulfate; Cineole; Niaouli Oil; Sulfathiazole | Disprofarma |
| Oto-Rinil | Prednazoline | Faria Laboratorio Farmaceutico |